Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

. 2016 Oct 20 ; 128 (16) : 2096-2097. [epub] 20160817

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu dopisy, komentáře

Perzistentní odkaz   https://www.medvik.cz/link/pmid27535995

Grantová podpora
P30 CA016672 NCI NIH HHS - United States

E-zdroje Online Plný text
Odkazy

PubMed 27535995
PubMed Central PMC5341483
DOI 10.1182/blood-2016-07-728766
PII: S0006-4971(20)34037-4
Knihovny.cz E-zdroje

Komentář

PubMed

Zobrazit více v PubMed

Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. PubMed

Brunning RD, Orazi A, Germing U, et al. Myelodysplastic syndromes/neoplasms. In: Swerdlow S, Campo E, Harris NL, et al., editors. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC Press; 2008. p. 88.

Wimazal F, Fonatsch C, Thalhammer R, et al. Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface. Leuk Res. 2007;31(11):1461–1468. PubMed

Kwok B, Hall JM, Witte JS, et al. MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance. Blood. 2015;126(21):2355–2361. PubMed PMC

Valent P, Bain BJ, Bennett JM, et al. Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS. Leuk Res. 2012;36(1):1–5. PubMed

Valent P, Jäger E, Mitterbauer-Hohendanner G, et al. Idiopathic bone marrow dysplasia of unknown significance (IDUS): definition, pathogenesis, follow up, and prognosis. Am J Cancer Res. 2011;1(4):531–541. PubMed PMC

Steensma DP, Bejar R, Jaiswal S, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015;126(1):9–16. PubMed PMC

McKerrell T, Park N, Moreno T, et al. Understanding Society Scientific Group. Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell Reports. 2015;10(8):1239–1245. PubMed PMC

Cargo CA, Rowbotham N, Evans PA, et al. Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression. Blood. 2015;126(21):2362–2365. PubMed

Greenberg PL, Stone R, Bejar R, et al. NCCN Practice Guidelines for Myelodysplastic Syndromes, version 1. 2017. ( www.nccn.org/professionals/physician_gls/PDF/mds.pdf) PubMed

Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89(6):2079–2088. PubMed

Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454–2465. PubMed PMC

Germing U, Strupp C, Kuendgen A, et al. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. Haematologica. 2006;91(12):1596–1604. PubMed

Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006;107(5):1747–1750. PubMed PMC

Beutler E. Hemoglobin levels, altitude, and smoking. Blood. 2006;108(6):2131–2132. PubMed

Segal JB, Moliterno AR. Platelet counts differ by sex, ethnicity, and age in the United States. Ann Epidemiol. 2006;16(2):123–130. PubMed

Biino G, Santimone I, Minelli C, et al. Age- and sex-related variations in platelet count in Italy: a proposal of reference ranges based on 40987 subjects’ data. PLoS One. 2013;8(1):e54289. PubMed PMC

Bain BJ. Ethnic and sex differences in the total and differential white cell count and platelet count. J Clin Pathol. 1996;49(8):664–666. PubMed PMC

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace